Skip to main content

Advertisement

Table 1 Demographic and clinical characteristics of women with PCOS in the three groups

From: Transvaginal ovarian drilling followed by controlled ovarian stimulation from the next day improves ovarian response for the poor responders with polycystic ovary syndrome during IVF treatment: a pilot study

VariablePoor responders (n = 7)High responders (n = 14)Normal responders (n = 14)P value
PCOS phenotype according to NIH subclassification [2, 18]
 Phenotype 17107
 Phenotype 2000
 Phenotype 3000
 Phenotype 4047
Age (years)31.43 ± 1.7229.86 ± 4.1330.29 ± 3.310.546
BMI (kg/m2)29.07 ± 2.1522.33 ± 3.39a23.47 ± 3.76a< 0.001
AFC18.64 ± 1.2114.36 ± 1.92ab12.57 ± 0.85a< 0.001
Basal FSH level (mIU/ml)6.45 ± 1.786.76 ± 1.796.57 ± 1.250.904
Basal LH level (mIU/ml)4.68 ± 2.087.17 ± 6.144.09 ± 1.800.147
Basal estradiol level (pg/ml)45.86 ± 19.8945.07 ± 19.9340.57 ± 15.120.747
Basal progesterone level (ng/ml)0.64 ± 0.280.68 ± 0.380.63 ± 0.600.965
PRL level (ng/ml)14.64 ± 6.2520.78 ± 10.9216.92 ± 5.450.239
AMH level (ng/ml)10.94 ± 3.80b7.50 ± 4.92b2.33 ± 2.08< 0.001
Testosterone level before CPA treatment (ng/ml)1.02 ± 0.300.69 ± 0.30c0.57 ± 0.21a0.003
Testosterone level after CPA treatment (ng/ml)0.55 ± 0.140.61 ± 0.120.57 ± 0.210.722
No. of previous stimulated cycles1621
No. of previous canceled cycles1600
  1. Data are presented as mean ± SD. Statistical significance was defined as P < 0.05. “a” refers to P < 0.01, relative to poor responders. “b” refers to P < 0.01, relative to normal responders. “c” refers to P < 0.05, relative to poor responders